Case Updates

The Court approved the settlement of the stockholder derivative action brought on behalf of Twitter, Inc. (“Twitter”) against several of Twitter’s current and former directors and officers for breach of fiduciary duties.

On April 22, 2021, the Hon. Janis L. Sammartino entered an Order preliminarily approving a $4,800,000 class action settlement on behalf of all Persons who purchased or otherwise acquired Orexigen publicly-traded securitiesbetween March 3, 2015 and May 12, 2015.

KSF’s stockholder derivative action was brought on behalf of Twitter, Inc. (“Twitter”) against several of Twitter’s current and former directors and officers for breach of fiduciary duties. On December 17, 2020, plaintiffs were able to secure a settlement providing that Twitter’s board of directors will pay $38 million in cash to Twitter and $8.75 million in attorney fees and court costs.

The Hon. Thomas P. Barber, United States District Court Judge for the Middle District of Florida, entered an Order preliminarily approving a $2,800,000 class action settlement on behalf of all Persons or entities who purchased or otherwise acquired HIIQ publicly-traded securities between August 4, 2017 and September 11, 2017, inclusive.

The Hon. Arthur J. Tarnow issued an Order granting Plaintiffs’ motion for class certification in its entirety in Dougherty v. Esperion Therapeutics, Inc.